Clinical Study to Evaluate the Impact of aKwa Skincare System on Skin Health
The Effects of äKwä Premium Skincare System on Improving Overall Skin Health and Beauty in Adults: An Exploratory Placebo-Controlled Clinical Study
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Utah
-
Sandy, Utah, United States, 84070
- 4Life Research
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Individuals could participate who were at least 18 years old and in good health.
Exclusion Criteria:
- had allergies or contraindications to any ingredient of products,
- had a history of any acute or chronic disease that could interfere with or increase the risk of study participation
- had any medical procedures, such as laser resurfacing, or plastic surgery to the test sites within the last 12 months (including Botox, Restylyn, or other fillers)
- chronic skin allergies (dermatitis, eczema, psoriasis)
- had been treated for skin cancer within the last 12 months or have damaged skin near the facial area (e.g., sunburn, tattoos, scars, or other disfigurations)
- pregnant or planning to become pregnant in the following 12 weeks, or lactating
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: äKwä Group
participants use äKwä products daily as instructed for 30 days
|
The skincare product system tested in this study was äKwä 6-step skincare system from 4Life Research USA, LLC ( https://www.4life.com/6613461/page/äKwä). Product directions state to use the following products morning and night in sequential order: First Wave Oil-to-Foam Cleanser, Glacier Glow Four-Way Toner, Precious Pool Vitamin Essence, Ripple Refine Eye Cream, and RainBurst Moisture Cream.
|
|
Active Comparator: Control Group
participants use a competitor products daily as instructed for 30 days
|
Participants use whatever their normal daily routine of skincare products, which are commercially available competitor products from the marketplace.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Skin Hydration
Time Frame: 30 days
|
measure facial skin moisture level at pre-defined spots, with SkinFit instrument
|
30 days
|
|
Red Spot Count
Time Frame: 30 days
|
measure the number of facial red spots at predefined areas, with SkinFit instrument
|
30 days
|
|
Red Vascular Count
Time Frame: 30 days
|
measure the number of facial red vasculature at predefined areas, with SkinFit instrument
|
30 days
|
|
Porphyrin Count
Time Frame: 30 days
|
measure the number of facial porphyrin at predefined areas, with SkinFit instrument
|
30 days
|
|
Wrinkles
Time Frame: 30 days
|
measure the number of wrinkles and fine lines at predefined areas, with SkinFit instrument
|
30 days
|
|
Pores
Time Frame: 30 days
|
measure the number of skin pores at predefined areas, with SkinFit instrument
|
30 days
|
|
Texture
Time Frame: 30 days
|
measure the number of uneven skin textures, at predefined areas, with SkinFit instrument
|
30 days
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Chair: David Vollmer, PhD, 4LIFE
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- RSC-017-00
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.